Nathali Kaushansky Selected Research

HLA-DR15 antigen

6/2015	Role of a Novel Human Leukocyte Antigen-DQA101:02;DRB115:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.
1/2014	DQB106:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB106:02 as a Disease-Predisposing Allele.
9/2009	HLA-DQB10602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB11501;DQB1*0602) transgenic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathali Kaushansky Research Topics

Disease

18	Multiple Sclerosis 01/2016 - 02/2006
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016 - 11/2006
5	Inflammation (Inflammations) 01/2017 - 03/2015
3	Disease Susceptibility (Diathesis) 06/2015 - 09/2009
2	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 01/2016
2	Colitis 01/2017 - 02/2016
2	Neuroinflammatory Diseases 01/2016 - 08/2011
2	Optic Neuritis (Retrobulbar Neuritis) 11/2008 - 11/2006
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2020
1	Ganglion Cysts (Ganglion) 01/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2020
1	Leukemia 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2016
1	Autoimmune Diseases of the Nervous System 12/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2011

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 06/2015 - 11/2006
5	CannabidiolIBA 01/2016 - 08/2011
4	Myelin-Oligodendrocyte GlycoproteinIBA 01/2016 - 02/2006
4	CannabinoidsIBA 01/2016 - 12/2013
4	AntigensIBA 06/2015 - 02/2006
3	Interleukin-17 (Interleukin 17)IBA 01/2016 - 12/2013
3	HLA-DR15 antigenIBA 06/2015 - 09/2009
3	ClaudinsIBA 06/2015 - 07/2007
3	EpitopesIBA 01/2011 - 11/2006
2	CytokinesIBA 01/2017 - 01/2016
2	HLA-DRB1 Chains (HLA DRB1)IBA 06/2015 - 01/2014
2	Peptides (Polypeptides)IBA 01/2011 - 11/2006
1	Dasatinib (BMS 354825)FDA Link 12/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Lenalidomide (CC 5013)FDA Link 01/2018
1	Therapeutic UsesIBA 01/2018
1	Chemokine ReceptorsIBA 01/2017
1	SodiumIBA 02/2016
1	Sulfates (Sulfates, Inorganic)IBA 02/2016
1	TetraspaninsIBA 02/2016
1	Chemokine CXCL12IBA 01/2016
1	ChemokinesIBA 01/2016
1	AntioxidantsIBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2015
1	HLA-DQA1 antigen (HLA DQA1)IBA 06/2015
1	Pharmaceutical PreparationsIBA 11/2014
1	Dronabinol (THC)FDA LinkGeneric 12/2013
1	Myelin Basic ProteinIBA 02/2012
1	Myelin Proteolipid ProteinIBA 02/2012
1	AutoantigensIBA 02/2010
1	HLA-DQB1 antigen (HLA DQB1)IBA 09/2009
1	Myelin ProteinsIBA 11/2007

Therapy/Procedure

3	Therapeutics 12/2020 - 01/2011